Study design considerations to assess the impact of potential drug–drug interactions in first‐in‐human studies in oncology drug development

Affiliations

Sriram Subramaniam: US Food and Drug Administration Silver Spring Maryland USA
Stacy S. Shord: US Food and Drug Administration Silver Spring Maryland USA
Ruby Leong: US Food and Drug Administration Silver Spring Maryland USA
Kelly Norsworthy: US Food and Drug Administration Silver Spring Maryland USA
Atiqur Rahman: US Food and Drug Administration Silver Spring Maryland USA
Brian Booth: US Food and Drug Administration Silver Spring Maryland USA
Olanrewaju Okusanya: US Food and Drug Administration Silver Spring Maryland USA

Abstract

No abstracts available.

ISSN: 1752-8054 (Print); 1752-8062 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Therapeutics. Pharmacology; Medicine: Public aspects of medicine
Website: http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1752-8062